Clinical Trial

Study of SYN818 With Olaparib for the Treatment of Locally Advanced or Metastatic Solid Tumors

Name: Study of SYN818 With Olaparib for the Treatment of Locally Advanced or Metastatic Solid Tumors — clinical trial record (NCT07156253)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

This interventional study will evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics and preliminary efficacy of SYN818 with Olaparib in adult patients with locally advanced or metastatic solid tumors

Trial Details

NCT Number	NCT07156253
Lead Sponsor	Hangzhou SynRx Therapeutics Biomedical Technology Co., Ltd
Conditions	Metastatic Solid Tumor, Ovarian Cancer, Breast Cancer, BRCA 1 /2 and / or HRD, Advanced Solid Tumors
Enrollment	110 participants
Start Date	2025-08-26
Primary Completion	2028-08-25 (estimated)
Study Completion	2029-02-25 (estimated)
Updated on ClinicalTrials.gov	2025-09-05